Bayer Schering

News Bayer Schering

• Lead Discovery Center and Bayer enter into license agreement covering a novel pharmaceutical lead structure

  The Lead Discovery Center GmbH (LDC), based in Dortmund, Germany, a spin-off from Max-Planck-Innovation GmbH (MI) in Munich, with expertise in small molecule pharmaceutical drug discovery, has successfully licensed its first lead structure to a pharma partner. The agreement grants Bayer Schering Pha more

• Organizational changes at Bayer HealthCare

  Bayer HealthCare has presented a number of measures to implement the initiatives for more innovation and growth announced in November 2010. The Bayer subgroup plans to streamline its administration functions in Germany and the United States. This measure and the consolidation of the U.S. sites a more

• Algeta appoints Lars Abrahmsén as Senior Vice President, Protein Therapeutics

  Algeta ASA announced that Dr. Lars Abrahmsén has been appointed as Senior Vice President, Protein Therapeutics and will take up this new role on 15 November 2010. Dr. Abrahmsén will be responsible for the development of Algeta's Thorium platform and for building and overseeing the preclinical deve more

Publications Bayer Schering

• The discovery and development of rivaroxaban

  Thromboembolic conditions present a considerable challenge to healthcare services because they are associated with substantial morbidity and mortality. The mainstays of prevention and treatment are anticoagulants and antiplatelet agents. Established anticoagulants have drawbacks that make their us more

Market studies Bayer Schering

• World Influenza Vaccines Market 2011-2021

  Are you looking for influenza vaccine market data - answers to benefit your work? Our new report shows you revenue prospects for the manufacture and sale of influenza vaccines from 2009 to 2021. There, you will see commercial opportunities for influenza vaccines - original research, data and opini more

• World Biological Drugs Market 2011-2021

  Do you want to find market prospects for products and companies in the biological drugs industry? Our new report shows you biopharma revenue forecasts for 2011 to 2021. We provide original research, data and opinions to benefit your work now. What revenues will biopharmaceutical markets achieve fro more

• World Anti-Obesity Drug Market 2011-2021

  What will this decade hold for the challenged anti-obesity drug industry and market? Our new report gives you revenue forecasts at world, product and national level. We provide original research, data and opinions to benefit your work. By ordering now, you can stay ahead. We aim to save you time a more

Websites Bayer Schering